Replies to post #2000 on 3D Printing Stocks

[r0und3r]

You will find that within the last 3 years of growth the OS has about doubled. On the surface it is a red flag, yes, but it was necessary in order to raise the funds for R&D of the start-up. The fluctuations of the PPS has pretty much reflected this dilution accordingly. If you do some DD on the subject you will notice a long flat line in the PPS for a couple years at around .01 when they started placing shares to raise capital, during which time some investors accumulated many of the PP shares, as I doubt the investing parties held on to them at that level for 2 years. Then there was the small run in early 2013, then another in mid 2013 both which corrected dramatically, then a HUGE run to .28 at the end of 2013 and the resulting huge correction at the beginning of 2014.

During all of these ups and downs, there was more than ample time for any of the PP holders of most of those placement shares to sell them into the market. I believe that they did just that. All but maybe a few.

On the other end, you had new investors accumulating shares of SGLB after performing their DD on the company (myself included.

It seems that PrintRite3D is close to generating revenue for Sigma Labs, once that begins, the clean up the share structure will likely be under way.

We held a very nice support above .12 after the big correction of the 3D printing sector since the beginning of the year. I believe that SGLB is actually ahead of the correction curve at this point.

My main focus right now not so much the share structure, but the market cap. Even after any sort of restructure, the market cap would reflect the same. Currently $82M. Many would argue how one can place that market cap on a company that is not bringing in big revenue. Unrealized potential is what drives it. The service that the PrintRite3D product will provide to additive metal manufacturing has to potential to dwarf $82M with in a couple of year. I have seen market caps run much higher in companies that offer much less potential.

There are obviously ALOT of us who are willing to hold at these levels and wait it out, as the support held very well above .12

With big news about GE or commercialization announcements I believe that that market cap based on unrealized future potential will go much higher. We have a strong base of investor in place now, and I said it at .12 since January, this is the perfect time to make an entry or add SGLB.

This is all obviously conjecture, but it is what it is. My .02

I look forward to your feedback after you do your own DD.

[BiotechValues]

That's a good question on the SGLB share count.

When I spoke with the CEO about it last year, he pretty much admitted that they made a mistake at the time of the reverse merger. They started off with over 400,000 shares at the time...relying on bad advice from the folks who put the deal together. Being engineers (and probably not as market-wise as they now are), they went ahead and actually started out with a boatload of shares.

The stock still manages to make 3-5% moves in a day with regularity- so it actually does trade as though it had a much smaller float.

The dilution from 2 capital raises in last 12 months hasn't helped either of course, but as of Dec. 31 they had a working capital surplus of just over $1 million and no debt.

In January they raised about $3.3 million if I recall, and that will be used for commercialization of PrintRite 3D.

It's a fascinating company- not without risks of course...but it's one of only very few penny stocks I believe will make it in this space.